Spotlight on Cardio-oncology: Managing CV-related Toxicities In Hematological Malignancies
Learn about managing cardiovascular-related toxicities in hematological malignancies including CLL, lymphoma, amyloidosis, AML & MDS.
Related Articles
Delayed Diagnosis Leads to Stage IV Thyroid Cancer, Medical Malpractice Lawsuit
A patient’s delayed cancer diagnosis led to a medical malpractice lawsuit against her primary care doctor and endocrinologist.
SEER*Explorer Application
SEER*Explorer provides access to SEER cancer statistics and detailed statistics for a cancer site by gender, race, calendar year, age, and for a selected number…
Discussion: should less intensive therapy be used in all older newly diagnosed pts with AML, even if fit for intensive chemo?
In this video, Jessica Altman, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, leads an insightful discussion with experts Eunice Wang,…
Interactive Maps
Tip: Hover on a state to see its rate (and 95% C.I.). Click a state to show its counties.
Recommendations to promote equity, diversity and inclusion in decentralized clinical trials – Nature Medicine
Digitally enabled and decentralized clinical trials could enable large-scale recruitment of diverse participants—but careful consideration of the barriers faced by underserved groups will be crucial…
Sacituzumab Tirumotecan NDA for Pretreated EGFR+ NSCLC Accepted for Review in China
An NDA seeking the approval of sacituzumab tirumotecan for EGFR-mutant non–small cell lung cancer is under review by the NMPA’s CDE.
Clonal Lineage Tracing with Somatic Delivery of Recordable Barcodes Reveals Migration Histories of Metastatic Prostate Cancer
Applying a recordable barcode in a prostate cancer model delineates the clonal architecture, seeding topologies, and routes taken by distinct cancer clones that traverse metastatic…
The OncoAlert Newsletter is NOW OUT Click to Register
The OncoAlert Newsletter is now out for June 23-29, 2023
BSH Abstract Submission | Haematology Abstracts
Submitting an abstract for BSH2023 will provide you with the opportunity to promote your research to a wide audience of haematology professionals.
